Similarly, to inhibit the growth of mammary cancers, NFkB inhibiting peptide p50 conjugated with SynB1 and ELP also exhibited improved tumor penetration while inducing apoptosis, inhibiting breast cancer cell growth and blocking the intranuclear import of NFkB [64]. Here, NR5A1 is linked to breast cancer.